Literature DB >> 3902848

Trans-oral approach to the upper cervical spine. A report of 16 cases.

G Bonney, J P Williams.   

Abstract

We report 16 cases in which the upper cervical spine was approached through the mouth for operative decompression and stabilisation, with or without removal of diseased tissues. The indications are discussed and the technique is described. Results are compared with those of other reported series. We believe that this operation has a place in the treatment of certain conditions affecting the upper part of the cervical spine and the foramen magnum, with or without involvement of the medulla and spinal cord.

Mesh:

Year:  1985        PMID: 3902848

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  6 in total

1.  Anterolateral and posterolateral approaches to the foramen magnum: technical description and experience from 97 cases.

Authors:  B George; G Lot
Journal:  Skull Base Surg       Date:  1995

2.  Open-door maxillotomy approach for lesions of the clivus.

Authors:  V K Anand; H L Harkey; O Al-Mefty
Journal:  Skull Base Surg       Date:  1991

3.  Postoperative Lemierre's syndrome: a previously unreported complication of transoral surgery. Illustrative case.

Authors:  Giuseppe Mariniello; Sergio Corvino; Giuseppe Teodonno; Serena Pagano; Francesco Maiuri
Journal:  J Neurosurg Case Lessons       Date:  2021-04-26

4.  Transoral transpalatal removal of a giant premesencephalic clivus chordoma.

Authors:  V Seifert; R Laszig
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

5.  Craniocervical junction malformation treated by transoral approach. A survey of 25 cases with emphasis on postoperative instability and outcome.

Authors:  N Di Lorenzo
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

6.  Corrective surgery for deformity of the upper cervical spine due to ankylosing spondylitis.

Authors:  Bin Lin; Bi Zhang; Zhu-Mei Li; Qiu-Sheng Li
Journal:  Indian J Orthop       Date:  2014-03       Impact factor: 1.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.